How much do 68Ga-, 177Lu- and 131I-based radiopharmaceuticals contribute to the global radiation exposure of nuclear medicine staff? by L. Struelens, E. Aalbersberg, L. Beels, N. Cherbuin, Y. D’Asseler, F. De Monte, A. Lopez Medina, M. del Carmen Riveira Martin, W. Schoonjans, C. Terwinghe, S. Van den Block, F. Vanhavere, H. Zaidi, V. Schelfhout

Get full text